Search for Clinical Trial Results

Sponsored By

Myasthenia Gravis - 36 Studies Found

Status Study
Completed Study Name: Mycophenolate Mofetil in Myasthenia Gravis
Condition: Myasthenia Gravis
Date: 2006-01-31
Interventions: Drug: mycophenolate mofetil
Completed Study Name: Efficacy of Methotrexate in Myasthenia Gravis
Condition: Myasthenia Gravis
Date: 2008-12-23
Interventions:
  • Drug: Methotrexate 10 mg weekl
Active, not recruiting Study Name: Tissue Repository for Studies of Myasthenia Gravis
Condition: Myasthenia Gravis
Date: 2016-09-12
Interventions: Other: No interventions
Active, not recruiting Study Name: BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis
Condition: Myasthenia Gravis
Date: 2014-04-07
Interventions:
  • Drug: Rituximab Intervention (
Completed Study Name: FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients
Condition: Myasthenia Gravis
Date: 2006-03-29
Interventions:
  • Drug: tacrolimus oral

Recruiting Study Name: Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis.
Condition: Myasthenia Gravis
Date: 2017-02-10
Interventions:
  • Drug: UCB7665 UCB7665 will be

Completed Study Name: Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis
Condition: Generalized Myasthenia Gravis
Date: 2007-08-10
Interventions:
  • Biological: GB-0998 (Intravenous immunoglobulin)

Terminated Study Name: Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
Condition: Myasthenia Gravis
Date: 2007-01-18
Interventions: Biological: Hematopoietic Stem Cell Transplantation Autologous Hematopoietic Stem Cell Transplantation
Terminated Study Name: A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis
Condition: Myasthenia Gravis
Date: 2012-03-13
Interventions: Drug: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Participants will receive one dose of GM
Recruiting Study Name: Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis
Condition: Myasthenia Gravis, Generalized
Date: 2015-06-23
Interventions:
  • Drug: Placebo
  • Drug: CFZ533
Next >>>